Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-17 · accession 0001415889-22-011492 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-17 | 2022-11-17 | FENC | RALLIS CHRIS A | Dir | S - Sale | $7.99 | -333 | 30.0K | -1% | -$2,661 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-11-17 | S | D | 333 | $7.99 | 30,018 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan on November 17, 2022. |